Plain-English translation of NCT05245487 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lymphoma research guide →This is a research study that looks at how chemotherapy affects the DNA and blood cells of older patients with lymphoma. The researchers will collect blood samples at different points during your treatment to see how the medication changes your blood over time. By understanding these changes, doctors hope to better protect patients from serious side effects like infection or treatment-related leukemia.
Chemotherapy can sometimes damage blood cells in ways that lead to serious problems, especially in older patients. This study exists to figure out how often these problems happen, how they develop over time, and what doctors can do to prevent them or catch them early.
You likely qualify if…
You likely don't qualify if…
Your doctor will enroll you in the study at your local hospital. You'll have blood drawn three times: before you start this round of chemotherapy, partway through your treatment (usually before your 3rd or 4th dose), and 4–8 weeks after treatment ends. You'll also receive a short online survey about your quality of life. All your blood samples go to a central laboratory for analysis, and the results will be kept confidential from you and your doctor during the study.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Denmark
Collaborators
Aalborg University Hospital, Odense University Hospital
Enrollment target
~300 participants
Started
January 2022
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
60 Years and older
Last updated on clinicaltrials.gov in December 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Simon Husby, MD PhD
Rigshospitalet, Denmark
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.